ACADIA Pharmaceuticals
ACAD
#3486
Rank
HK$32.79 B
Marketcap
HK$193.85
Share price
0.81%
Change (1 day)
28.01%
Change (1 year)

Market capitalization of ACADIA Pharmaceuticals (ACAD)

Market cap: HK$32.79 Billion

As of February 2026 ACADIA Pharmaceuticals has a market cap of HK$32.79 Billion. This makes ACADIA Pharmaceuticals the world's 3486th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ACADIA Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$32.79 B-9.79%
2025HK$36.35 B66.05%
2024HK$21.89 B-45.46%
2023HK$40.14 B99.32%
2022HK$20.14 B-31.15%
2021HK$29.25 B-55.59%
2020HK$65.88 B27.35%
2019HK$51.73 B184.01%
2018HK$18.21 B-37.66%
2017HK$29.21 B7.88%
2016HK$27.08 B-3.84%
2015HK$28.16 B14.32%
2014HK$24.63 B39.56%
2013HK$17.65 B567.9%
2012HK$2.64 B496.78%
2011HK$0.44 B20.53%
2010HK$0.36 B-6.33%
2009HK$0.39 B51.73%
2008HK$0.25 B-91.91%
2007HK$3.19 B56.17%
2006HK$2.04 B59.1%
2005HK$1.28 B45.16%
2004HK$0.88 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of ACADIA Pharmaceuticals was reported to be:

HK$32.53 Billion
by Nasdaq info icon info icon
HK$32.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.603 T 13,936.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.196 T 3,547.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.660 T 23,256.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$976.43 B 2,877.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
HK$3.96 B-87.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
HK$2.94 B-91.03%๐Ÿ‡บ๐Ÿ‡ธ USA